Chemical Formula: C5H5N3O

Chemical Formula C5H5N3O

Found 20 metabolite its formula value is C5H5N3O

pyrazinamide

pyrazinamide

C5H5N3O (123.04326000000002)


J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS KEIO_ID P098

   

Pyrazinamide

Pyrazinecarboxylic acid amide

C5H5N3O (123.04326000000002)


Pyrazinamide is only found in individuals that have used or taken this drug. It is a pyrazine that is used therapeutically as an antitubercular agent.Pyrazinamide is an important sterilizing prodrug that shortens tuberculosis (TB) therapy. However, the mechanism of action of pyrazinamide is poorly understood because of its unusual properties. In literature it has been written that the pyrazinoic acid (POA), the active moiety of pyrazinamide, disrupted membrane energetics and inhibited membrane transport function at acid pH in Mycobacterium tuberculosis. The antimycobacterial activity appears to partly depend on conversion of the drug to POA. Susceptible strains of M. tuberculosis produce pyrazinamidase, an enzyme that deaminates pyrazinamide to POA, and the vitro susceptibility of a given strain of the organism appears to correspond to its pyrazinamidase activity. Experimental evidence suggests that pyrazinamide diffuses into M. tuberculosis in a passive manner, is converted into POA by pyrazinamidase, and because of an inefficient efflux system, accumulates in huge amounts in the bacterial cytoplasm. The accumulation of POA lowers the intracellular pH to a suboptimal level that is likely to inactivate a vital target enzyme such as fatty acid synthase. Recent studies (2007) demonstrated that pyrazinamide and its analogs inhibit the activity of purified FAS I. J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-(2-Pyrimidinyl)formamide

N-(pyrimidin-2-yl)formamide

C5H5N3O (123.04326000000002)


   

N-pyrimidin-5-ylformamide

N-(pyrimidin-5-yl)formamide

C5H5N3O (123.04326000000002)


   
   
   

1-methyl-1h-imidazol-5-yl isocyanate

1-methyl-1h-imidazol-5-yl isocyanate

C5H5N3O (123.04326000000002)


   
   

2-aminopyrimidine-4-carbaldehyde

2-aminopyrimidine-4-carbaldehyde

C5H5N3O (123.04326000000002)


   

1H-IMIDAZO[1,5-A]IMIDAZOL-5(6H)-ONE

1H-IMIDAZO[1,5-A]IMIDAZOL-5(6H)-ONE

C5H5N3O (123.04326000000002)


   

3-Aminopyrazine-2-carbaldehyde

3-Aminopyrazine-2-carbaldehyde

C5H5N3O (123.04326000000002)


   

(E)-N-Hydroxy-1-(4-pyrimidinyl)methanimine

(E)-N-Hydroxy-1-(4-pyrimidinyl)methanimine

C5H5N3O (123.04326000000002)


   

2-Aminopyrimidine-5-carbaldehyde

2-Aminopyrimidine-5-carbaldehyde

C5H5N3O (123.04326000000002)


   

4-aminopyrimidine-5-carbaldehyde

4-aminopyrimidine-5-carbaldehyde

C5H5N3O (123.04326000000002)


   

3-METHYL-[1,2,4]TRIAZINE-5-CARBALDEHYDE

3-METHYL-[1,2,4]TRIAZINE-5-CARBALDEHYDE

C5H5N3O (123.04326000000002)


   

1-(hydroxymethyl)pyrazole-3-carbonitrile

1-(hydroxymethyl)pyrazole-3-carbonitrile

C5H5N3O (123.04326000000002)


   

(E)-2-Pyrimidinecarboxaldehyde oxime

(E)-2-Pyrimidinecarboxaldehyde oxime

C5H5N3O (123.04326000000002)


   

5-Amino-3-methyl-4-isoxazolecarbonitrile

5-Amino-3-methyl-4-isoxazolecarbonitrile

C5H5N3O (123.04326000000002)


   

(5-methyl-1,3,4-oxadiazol-2-yl)acetonitrile(SALTDATA: FREE)

(5-methyl-1,3,4-oxadiazol-2-yl)acetonitrile(SALTDATA: FREE)

C5H5N3O (123.04326000000002)